SE‑Cluster

Search

Search markets, companies, evidence, and pages

TickerPHR
SectorMedical - Healthcare Information Services
Mkt cap$618M
EV / EBITDA21.9×
PostureHigh Velocity
Composite70/100
LensBuyer-side
SE-Cluster Research·Issuer Brief·Q2 2026CIK 1412408

Phreesia, Inc.

PHRHIGH VELOCITYFILING INTENSITY

Phreesia, Inc. reads as an High Velocity (composite 70/100); Consistent Strategic Buyer deploying $168M across 4 disclosed transactions, up 123% vs the prior cycle · primary market Marketing & Data.

Lens

Disclosed M&A capital (2023–2025)

$168M

+123%

vs $75M in 2020–2022

Disclosed transactions

4

+33%

2/3 active fiscal years in window

Buyer archetype

Consistent Strategic Buyer

Meaningful spend appears across repeat years.

Composite score

70

/100

High Velocity dominates · Filing Intensity

Financial snapshot
Revenue$481M
EBITDA$29M
Enterprise value$647M
EV / Revenue1.3×
EV / EBITDA21.9×
P/EN/A
Cash$74M
Total debt$3M
as of 2026-05-10
§ I·SE-Cluster Issuer Brief

Behavioral posture, nine reads.

Each index scores the issuer 0–100 against an EDGAR-anchored definition. Scores ≥ threshold elevate the issuer into the index's constituent set; the dominant index drives the masthead label.

Active Acquirer

29/100

Companies actively deploying disclosed capital into M&A

  • $243M disclosed buyer spend

Buyer Cadence

36/100

Buyer-side companies with recent filing activity

  • Filed within 36d
  • 63 8-Ks

Target Probability

4/100

Issuers showing target-side patterns from filings

Spin/Carve

0/100

Issuers showing spin-off, carve-out, or sum-of-parts posture

Pressure Watch

14/100

Issuers facing activism, governance, or control pressure

Distress Watch

19/100

Issuers showing financial-distress filing patterns

  • 10-Q 182d stale

Restatement Risk

0/100

Issuers with accounting-integrity flags from filings

Capital Velocity

Dominant
70/100

Issuers with the highest filing-activity intensity

  • 63 8-Ks
  • 4 form types

Quiet Power

20/100

Large issuers with low signal volume and clean disclosure cadence

  • Enterprise value $647M
  • 10-Q 182d ago
  • 2 active signals
§ II·SE-Cluster Issuer Brief

Capital cadence.

Ten-year disclosed M&A activity. Bars show spend ($MM); ticks show recorded transaction count. Disclosure tier annotated where v6 audited corpus carries an entry.

16
17
18
19
20
21
22
23
24
25

Disclosed spend $MM Disclosed transactions (right axis)Peak spend year: $153M · Peak count: 3

FYDisclosed buysDisclosed spendAvg ticketAudited tier
20251$153M$153MN/A
2024N/AN/AN/AN/A
20233$15M$5MN/A
20221$34M$34MN/A
2021N/A$34MN/AN/A
20202$7M$3MN/A
§ III·SE-Cluster Issuer Brief

Strategy posture.

The buyer's playbook in terms of strategic archetype: what each disclosed move says about how they're deploying capital.

Archetype mix

  • Bolt On
    33%
  • Technology Acquisition
    33%
  • Horizontal Consolidation
    33%

Strategy keywords

Terms recurring across recent 10-K acquisition disclosures.

  • bolt_on
  • technology_acquisition
  • horizontal_consolidation
§ IV·SE-Cluster Issuer Brief

Filing language.

Direct excerpts from acquisition disclosures and strategy sections: the verbs the buyer chose, in the filings they signed.

We compete on the basis of several factors. Some of our competitors have greater name recognition, longer operating histories and significantly greater resources than we do.

10-KFY2025

We target opportunities that enhance the breadth or depth of our ability to activate patients in their care.

10-KFY2021

AI technologies may make it easier for competitors to enter our market due to lower up-front costs.

10-KFY2025

Our acquisitions to date have all been consistent with this philosophy.

10-KFY2021

consolidation in the healthcare industry resulting in loss of clients;

10-KFY2023
§ V·SE-Cluster Issuer Brief

Market context.

Where this issuer sits inside its SE-Cluster rollup wedge, with disclosed-spend rank plus trading comparables against the public peer set.

Primary market

Marketing & Data

Market spend (2023–2025)
$51.4B
Market spend (2020–2022)
$63.5B
Recent vs prior
−19%
Issuer rank in market
N/A
Share of market capital
0.0%

Valuation positioning

21.9×EV / EBITDA

PHR trades at a -0.5-turn discount to the Marketing & Data peer median of 22.4×.

EV / Revenue
1.3×
Net debt / EBITDA
-2.4×
Peer median EV / EBITDA
22.4×

Trading comparables

FMP market data · 2026-05-10

CompanyEV / EBITDAEV / RevNet debt / EBITDARevenueM&A 2023–2025
22.4×11.6×-0.2×$422.6B$3.2B
Phreesia, Inc.PHR
21.9×1.3×-2.4×$481M$168M

Trading multiples from FMP market data; disclosed M&A spend from the SE-Cluster EDGAR 10-K corpus. Peer set = top disclosed buyers in Marketing & Data. Bars scaled to the highest EV/EBITDA in the set.

§ VI·SE-Cluster Issuer Brief

Target landscape.

Public-issuer targets that fit this buyer's archetype and target categories from filing-derived signal. Scores reflect cross-signal fit; reasons cite the EDGAR-anchored facts that drove the match.

No qualifying public-issuer targets surfaced from the current signal mix.

Stated target categories

No target categories enumerated in the audited corpus for this issuer.

§ VII·SE-Cluster Issuer Brief

Filing activity & signal stream.

Filing cadence and event-driven signals visible on EDGAR. The signal stream below is curated from restatement / spin-carve / activism categories, providing context for any near-term call.

Filing cadence

  • 10-K (annual)72026-03-31
  • 10-Q (quarterly)212025-12-09
  • 8-K (event)632026-05-04
  • Proxy / DEF 14A132025-05-14
  • Activism (13D / DFAN / PREC)0N/A

Signals on file

  • info

    Signal

    Serial acquisition history

  • info

    Signal

    10-K strategy themes

§ VIII·SE-Cluster Issuer Brief

Audited corpus.

No audited record on file for this CIK in the current v6 corpus.

This issuer has not been extracted into the v6 audited acquirer corpus yet. The brief above pulls from ranking-level aggregates and issuer-index signal only.